EUVIMEDEUVIMED entdecken
Crossref

The CCL2–CCR2 Axis Contributes to Migration of Cabazitaxel-resistant Prostate Cancer Cells

Ariunbold Natsagdorj, Kouji Izumi, Kaoru Hiratsuka, Renato Naito, Suguru Kadomoto, Hiroaki Iwamoto, Hiroshi Yaegashi, Kazuyoshi Shigehara, Hiroki Nakata, Atsushi Mizokami

Anticancer Research · 2023

DOI: 10.21873/anticanres.16423 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Ariunbold Natsagdorj und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Prostatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic Neoplasms, Castration-ResistantProstatic NeoplasmsMaleHumansDocetaxelProto-Oncogene Proteins c-aktCell Line, TumorDrug Resistance, NeoplasmRNA, Small InterferingChemokine CCL2Receptors, CCR2Taxoids

Stichwörter der Autor:innen

CCL2Migrationcabazitaxelchemo-resistanceprostate cancer

Substanzen

DocetaxelProto-Oncogene Proteins c-aktRNA, Small InterferingChemokine CCL2Receptors, CCR2cabazitaxelTaxoidsCCL2 protein, humanCCR2 protein, human

Autor:innen und Institutionen

  • Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • General Surgery, Grand Med Hospital, Ulaanbaatar, Mongolia.
  • Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan; azuizu2003@yahoo.co.jp.
  • Department of Clinical Engineering, Faculty of Health Sciences, Komatsu University, Komatsu, Japan.

Zitieren

APA

Natsagdorj, A., Izumi, K., Hiratsuka, K., Naito, R., Kadomoto, S., Iwamoto, H., Yaegashi, H., Shigehara, K., Nakata, H., & Mizokami, A. (2023). The CCL2–CCR2 Axis Contributes to Migration of Cabazitaxel-resistant Prostate Cancer Cells. Anticancer Research. https://doi.org/10.21873/anticanres.16423

Vancouver

Natsagdorj A, Izumi K, Hiratsuka K, Naito R, Kadomoto S, Iwamoto H, et al. The CCL2–CCR2 Axis Contributes to Migration of Cabazitaxel-resistant Prostate Cancer Cells. Anticancer Research. 2023. doi:10.21873/anticanres.16423

BibTeX
@article{Natsagdorj2023,
  author = {Natsagdorj, Ariunbold and Izumi, Kouji and Hiratsuka, Kaoru and Naito, Renato and Kadomoto, Suguru and Iwamoto, Hiroaki and Yaegashi, Hiroshi and Shigehara, Kazuyoshi and Nakata, Hiroki and Mizokami, Atsushi},
  title = {The CCL2–CCR2 Axis Contributes to Migration of Cabazitaxel-resistant Prostate Cancer Cells},
  journal = {Anticancer Research},
  year = {2023},
  doi = {10.21873/anticanres.16423}
}
Kostenlos starten →